We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about the connection between Kawasaki disease and COVID-19, its symptoms, diagnosis, treatment, and what parents in India need to know to protect their children.

The year 2020 brought a wave of uncertainty, didn't it? Amidst the global COVID-19 pandemic, a new concern emerged for parents, especially those with young children. Doctors and researchers observed a rise in a condition called Kawasaki disease, particularly in children under the age of five. This illness, which causes inflammation in blood vessels, seemed to be showing up more frequently. While the exact cause of Kawasaki disease remains a bit of a mystery, scientists believe that a combination of genetic predisposition and environmental triggers, like viral infections, might be at play. The novel coronavirus, SARS-CoV-2, the very virus that causes COVID-19, became a prime suspect in potentially triggering this inflammatory response in vulnerable children. Kawasaki disease isn't a new illness. It was first identified in the 1960s by a Japanese pediatrician, Dr. Tomisaku Kawasaki. Although it can occur anywhere, it seems to be more prevalent in certain parts of the world, including Japan. In India, like elsewhere, keeping a close watch on children's health is paramount, and understanding conditions like Kawasaki disease is vital for prompt recognition and care. Understanding Kawasaki Disease At its core, Kawasaki disease is an illness that affects the blood vessels. It causes them to become inflamed. This inflammation is a serious matter because it can potentially lead to significant health problems, particularly affecting the heart. The coronary arteries, which supply blood to the heart muscle, are especially at risk. If left untreated, this inflammation can lead to weakening of these arteries, potentially causing aneurysms (bulges in the artery wall) or even increasing the risk of heart attacks later in life. This is why early diagnosis and treatment are so incredibly important for these little ones. Key Symptoms to Watch For Recognizing Kawasaki disease early can make a world of difference. While not every child will show all the signs, here are the common symptoms that parents in India should be aware of: High Fever: A fever that lasts for five days or more, and doesn't respond well to typical fever-reducing medications, is often the first sign. Red Eyes: The whites of the eyes often become very red, but there's usually no discharge or crusting. Rash: A widespread rash can appear on the body, often looking like measles or scarlet fever. Redness and Swelling of Lips and Mouth: The lips might become very red, dry, and cracked. The inside of the mouth and the tongue can also appear red and swollen, sometimes described as a 'strawberry tongue.' Swollen Hands and Feet: The palms of the hands and soles of the feet can become red and swollen. Later, the skin on the fingers and toes might start to peel. Swollen Lymph Nodes: One or more lymph nodes in the neck might become enlarged, usually on one side. It's important to remember that sometimes, a child might not present with all five of the classic symptoms. This is what doctors refer to as 'atypical' Kawasaki disease. If your child has a persistent high fever, even without all the other signs, and especially if there are any concerns about their heart, it's essential to consult a doctor immediately. The COVID-19 Connection: What We Observed When the COVID-19 pandemic first swept across the globe, healthcare professionals noticed something concerning. Reports emerged from various countries, including studies from the UK and Italy, highlighting an unusual increase in children presenting with symptoms highly suggestive of Kawasaki disease, or conditions very similar to it. Some researchers even described this surge as 'unprecedented.' This led to intense investigation into a potential link between the novel coronavirus (SARS-CoV-2) and Kawasaki disease. The theory is that in some children, particularly those who might be genetically susceptible, infection with the coronavirus could trigger an overactive immune response. This exaggerated immune reaction can lead to the widespread inflammation characteristic of Kawasaki disease. It's like the body's defense system goes into overdrive, attacking its own blood vessels. Multisystem Inflammatory Syndrome in Children (MIS-C) It's also important to mention another condition that emerged during the pandemic: Multisystem Inflammatory Syndrome in Children (MIS-C). MIS-C shares many symptoms with Kawasaki disease, including fever, red eyes, and rash. Both conditions can also lead to serious heart problems. However, MIS-C can present with additional symptoms that are less common in typical Kawasaki disease. These can include: Gastrointestinal Issues: Severe abdominal pain, vomiting, diarrhea, and nausea are common. Neurological Symptoms: Headaches, confusion, or even signs of meningitis can occur. Extreme Immune Response: This can manifest as a 'cytokine storm,' where the immune system releases a flood of inflammatory chemicals. Low Blood Pressure: Signs of toxic shock syndrome, including a sudden drop in blood pressure, can be present. Organ Dysfunction: Other organs like the kidneys might be affected. A key difference often noted is that Kawasaki disease typically affects younger children (under 5), whereas MIS-C seems to affect a broader age range, including older children and adolescents. Distinguishing between Kawasaki disease and MIS-C is crucial for guiding the correct treatment approach. Diagnosis: Piecing Together the Puzzle Diagnosing Kawasaki disease isn't always straightforward, especially with atypical presentations. Doctors rely on a combination of clinical observation and diagnostic tests. The process usually involves: Detailed Medical History: Your doctor will ask about your child's symptoms, how long they've been present, any recent illnesses, and your family's medical history. Be prepared to describe everything you've observed. Physical Examination: A thorough examination will look for the characteristic signs of Kawasaki disease – the fever, red eyes, rash, changes in the mouth, and swelling or peeling of the hands and feet. Blood Tests: Blood tests help assess the level of inflammation in the body (e.g., C-reactive protein, ESR) and check for other potential causes of the symptoms. They can also evaluate organ function. Urine Tests: These can help rule out other infections. Echocardiogram: This is perhaps the most critical test. An echocardiogram (echo) is an ultrasound of the heart. It allows doctors to visualize the coronary arteries and check for any signs of inflammation, swelling, or aneurysm formation. This test is usually done shortly after diagnosis and may be repeated to monitor the heart's condition. The diagnosis is often made when a child has a persistent fever lasting at least five days, along with at least four of the characteristic symptoms. However, as mentioned, if coronary artery abnormalities are present on the echo, a diagnosis can be made even with fewer symptoms. Treatment: Protecting the Heart The primary goal of treating Kawasaki disease is to reduce inflammation and prevent damage to the coronary arteries. Prompt treatment is key to a good outcome. The standard treatment usually involves: Intravenous Immunoglobulin (IVIG): This is the cornerstone of treatment. IVIG is a concentrated dose of antibodies derived from donated blood. It helps to calm the overactive immune system and reduce inflammation. It's typically given as an infusion over several hours. Aspirin: Children with Kawasaki disease are usually given high doses of aspirin initially to reduce fever and inflammation. Once the fever subsides and there are no signs of coronary artery problems, the dose is reduced to a low dose for several weeks to prevent blood clots. (Note: Aspirin use in children should always be under strict medical supervision due to the risk of Reye's syndrome.) For children who don't respond well to the initial IVIG treatment, doctors might consider other medications, such as corticosteroids or other immunosuppressants. Prevention: What Can You Do? Currently, there are no specific proven ways to prevent Kawasaki disease. Since the exact cause is unknown and it's thought to be triggered by infections in genetically susceptible children, prevention strategies are limited. However, general good hygiene practices that help prevent the spread of infections, including COVID-19, are always beneficial. This includes: Frequent handwashing with soap and water. Teaching children good coughing and sneezing etiquette. Ensuring children are up-to-date with all recommended vaccinations. Avoiding close contact with individuals who are sick. While these measures won't directly prevent Kawasaki disease, they contribute to overall child health and reduce the risk of various infections that could potentially trigger inflammatory conditions. When to Consult a Doctor Immediately As a parent in India, your vigilance is your child's best defense. You should seek immediate medical attention if your child: Has a high fever that lasts for more than four days. Develops a rash, especially if accompanied by fever. Has unusually red eyes without discharge. Complains of a sore throat or has a very red, cracked tongue. Experiences swelling or redness in their hands or feet. Seems unusually irritable or lethargic, especially with a fever. If your child has recently recovered from COVID-19 or has symptoms suggestive of COVID-19 and then develops any of the symptoms listed above, it is even more critical to seek medical help promptly. Be sure to inform the doctor about any recent infections, including COVID-19. Frequently Asked Questions (FAQs) Q1: Is Kawasaki disease contagious? Kawasaki disease itself is not thought to be contagious from person to person. However, it's believed to be triggered by an infection, and infections can spread. So, while
In summary, timely diagnosis, evidence-based treatment, and prevention-focused care improve long-term health outcomes.

Understand the peripheral blood smear test for malaria diagnosis, its procedure, and what results mean for patients.
April 20, 2026

Discover how specialized staining techniques, like Giemsa, are crucial for accurately diagnosing Leishmaniasis, identifying the parasite, and guiding timely treatment. Understand this key diagnostic approach.
April 20, 2026

Understand the peripheral blood smear test for malaria diagnosis, its procedure, and why it's a vital tool in combating this disease.
April 20, 2026